ACLARIS THERAPEUTICS, INC. Toevoegen aan een lijst
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 1,2 USD | +0,84% |
|
-3,23% | +14,29% |
Totale waarde
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Marktkapitalisatie 1 | 78,22 | 277,7 | 890,2 | 1.050 | 74,38 | 85,52 | - | - |
| Bedrijfswaarde 1 | 78,22 | 277,7 | 890,2 | 820,5 | -44,73 | 14,28 | -71,9 | 5,374 |
| K/w-verhouding | -0,48 x | -5,39 x | -9,09 x | -11,8 x | -0,83 x | -1,23 x | -1,32 x | -1,34 x |
| Dividendrendement | - | - | - | - | - | - | - | - |
| Marktkapitalisatie/omzet | 18,5 x | 42,8 x | 132 x | 35,3 x | 2,38 x | 11 x | 9,84 x | 8,51 x |
| Bedrijfswaarde/omzet | 18,5 x | 42,8 x | 132 x | 27,6 x | -1,43 x | 1,84 x | -8,28 x | 0,53 x |
| Bedrijfswaarde/EBITDA | -0,91 x | - | - | -9,21 x | 0,46 x | -0,15 x | 0,95 x | -0,07 x |
| Bedrijfswaarde/FCF | - | - | -17 x | -12 x | 0,56 x | -0,84 x | 1,27 x | -0,09 x |
| FCF Yield | - | - | -5,89% | -8,31% | 178% | -119% | 78,7% | -1.129% |
| Price to Book | - | - | - | - | - | - | - | - |
| Aantal aandelen (in duizenden) | 41.388 | 42.919 | 61.227 | 66.683 | 70.836 | 71.265 | - | - |
| Referentieprijs 2 | 1,890 | 6,470 | 14,54 | 15,75 | 1,050 | 1,200 | 1,200 | 1,200 |
| Datum van publicatie | 25/02/20 | 25/02/21 | 24/02/22 | 23/02/23 | 27/02/24 | - | - | - |
1USD in Miljoen2USD
Geschatte gegevens
Evolutie van de resultatenrekening (Jaargegevens)
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 4,227 | 6,482 | 6,761 | 29,75 | 31,25 | 7,756 | 8,688 | 10,05 |
| EBITDA 1 | -86,14 | - | - | -89,06 | -96,49 | -93,51 | -75,67 | -77,73 |
| Bedrijfsresultaat (EBIT) 1 | -92,55 | -50,91 | -89,72 | -89,85 | -97,36 | -61,51 | -60,48 | -86,43 |
| Operationele Marge | -2.189,59% | -785,44% | -1.327,07% | -302,01% | -311,55% | -793% | -696,14% | -860,15% |
| Resultaat voor belastingen (EBT) 1 | -113,5 | -51,34 | -90,86 | -86,91 | -88,85 | -76,12 | -71,06 | -87,93 |
| Nettowinst (verlies) 1 | -161,4 | -51,02 | -90,86 | -86,91 | -88,48 | -73,66 | -70,72 | -83,6 |
| Nettomarge | -3.817,22% | -787,03% | -1.343,96% | -292,11% | -283,15% | -949,75% | -813,94% | -831,98% |
| WPA 2 | -3,900 | -1,200 | -1,600 | -1,330 | -1,270 | -0,9750 | -0,9071 | -0,8975 |
| Free Cash Flow 1 | - | - | -52,44 | -68,17 | -79,63 | -17 | -56,6 | -60,67 |
| FCF-marge | - | - | -775,65% | -229,13% | -254,84% | -219,19% | -651,47% | -603,77% |
| Kasstroomconversie (ebitda) | - | - | - | - | - | - | - | - |
| Kasstroomconversie (nettowinst) | - | - | - | - | - | - | - | - |
| Dividend per aandeel | - | - | - | - | - | - | - | - |
| Datum van publicatie | 25/02/20 | 25/02/21 | 24/02/22 | 23/02/23 | 27/02/24 | - | - | - |
1USD in Miljoen2USD
Geschatte gegevens
Evolutie van de resultatenrekening (Kwartaalgegevens)
| Fiscaal tijdperk: december | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 1,659 | 1,501 | 1,453 | 1,528 | 19,02 | 7,753 | 2,528 | 1,869 | 9,282 | 17,57 | 2 | 2,006 | 2,056 | 2,063 | 1,233 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Bedrijfsresultaat (EBIT) 1 | -20,3 | -22,89 | -18,91 | -20,99 | -20,87 | -29,08 | -29,92 | -31,82 | -31,58 | -4,047 | -14,32 | -14,17 | -13,89 | -14,47 | -35,39 |
| Operationele Marge | -1.223,33% | -1.525,18% | -1.301,24% | -1.373,95% | -109,76% | -375,07% | -1.183,47% | -1.702,25% | -340,2% | -23,03% | -715,81% | -706,39% | -675,44% | -701,5% | -2.870,48% |
| Resultaat voor belastingen (EBT) 1 | -21,15 | -22,8 | -18,79 | -20,53 | -19,95 | -27,64 | -28,16 | -29,57 | -29,26 | -1,858 | -20,36 | -18,19 | -17,06 | -16,92 | -34,89 |
| Nettowinst (verlies) 1 | -21,15 | -22,8 | -18,79 | -20,53 | -19,95 | -27,64 | -28,16 | -29,57 | -29,26 | -1,491 | -20,32 | -17,96 | -16,43 | -16,04 | -34,89 |
| Nettomarge | -1.274,62% | -1.519,25% | -1.293,12% | -1.343,72% | -104,91% | -356,44% | -1.113,92% | -1.582,08% | -315,24% | -8,49% | -1.016,11% | -895,14% | -799,05% | -777,74% | -2.829,93% |
| WPA 2 | -0,3500 | -0,3700 | -0,3100 | -0,3100 | -0,3000 | -0,4100 | -0,4200 | -0,4200 | -0,4100 | -0,0200 | -0,2700 | -0,2357 | -0,2143 | -0,2086 | -0,2400 |
| Dividend per aandeel | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Datum van publicatie | 2/11/21 | 24/02/22 | 10/05/22 | 3/08/22 | 8/11/22 | 23/02/23 | 8/05/23 | 7/08/23 | 6/11/23 | 27/02/24 | - | - | - | - | - |
1USD in Miljoen2USD
Geschatte gegevens
Balans
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Nettoschuldpositie 1 | - | - | - | - | - | - | - | - |
| Nettokaspositie 1 | - | - | - | 230 | 119 | 71,2 | 157 | 80,1 |
| Hefboom (schuld/ebitda) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | - | -52,4 | -68,2 | -79,6 | -17 | -56,6 | -60,7 |
| ROE (netto-inkomsten/eigen vermogen) | - | - | - | - | - | - | - | - |
| ROA (netto-inkomsten/totale activa) | - | - | - | - | - | - | - | - |
| Totale activa 1 | - | - | - | - | - | - | - | - |
| Nettoactief per aandeel | - | - | - | - | - | - | - | - |
| Cashflow per aandeel | - | - | - | - | - | - | - | - |
| Capex 1 | 1,61 | 0,45 | 0,31 | 0,61 | 1,31 | 1 | 1 | 1 |
| Capex/omzet | 38,16% | 6,99% | 4,56% | 2,03% | 4,19% | 12,89% | 11,51% | 9,95% |
| Datum van publicatie | 25/02/20 | 25/02/21 | 24/02/22 | 23/02/23 | 27/02/24 | - | - | - |
1USD in Miljoen
Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Historische marktkapitalisatie/EBITDA
Trading rating
Beleggingsrating
ESG Refinitiv
C-
Verkoop
Koop
Gemiddeld advies
Houden
Aantal analisten
8
Laatste slotkoers
1,2
USD
Gemiddelde koersdoel
1,8
USD
Spread / Gemiddelde doel
+50,00%
Herzieningen van WPA
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| +14,29% | 85,52 mln. | |
| +1,51% | 42,75 mld. | |
| +49,22% | 41,61 mld. | |
| +8,57% | 41,34 mld. | |
| -12,36% | 26,59 mld. | |
| +8,92% | 25,49 mld. | |
| -25,13% | 18,12 mld. | |
| +29,17% | 12,24 mld. | |
| -3,12% | 11,76 mld. | |
| +6,35% | 11 mld. |
- Beurs
- Aandelen
- Koers ACRS
- Financiën Aclaris Therapeutics, Inc.
